Literature DB >> 8019456

Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes.

C A Schmidt1, H Oettle, F Wilborn, J Jessen, H Timm, R Schwerdtfeger, J Oertel, W Siegert.   

Abstract

We prospectively monitored buffy coat leukocytes of 47 patients after 50 marrow transplantations (autologous n = 18, allogeneic n = 32) by polymerase chain reaction (PCR) for the presence of cytomegalovirus (CMV). None of the 18 autologous graft recipients (9 seropositive, 9 seronegative) had positive PCR results or CMV disease throughout the post-transplantation course. Six of 32 allograft recipients (19 seropositive, 13 seronegative) became PCR positive, four of whom developed CMV disease. PCR positive patients were found more often (5 of 10) in the group with acute GVHD grade II-IV compared with 1 of 22 in the group without or with grade I acute GVHD (p = 0.002). Comparison of PCR with antigen assay and virus culture showed an agreement in 90 of 96 (94%) samples. Discordant results were due to a higher sensitivity of the PCR compared with antigen assay (n = 4) and virus culture (n = 6). In conclusion, PCR helps to identify those patients who will not develop CMV disease and narrows down the number of patients who eventually will suffer symptomatic CMV infection. Furthermore, PCR is a useful tool for following the post-transplantation course with respect to CMV and for judging the effect of antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019456

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Detection of human cytomegalovirus DNA by real-time quantitative PCR.

Authors:  A Nitsche; N Steuer; C A Schmidt; O Landt; H Ellerbrok; G Pauli; W Siegert
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures.

Authors:  J Gozlan; J P Laporte; S Lesage; M Labopin; A Najman; N C Gorin; J C Petit
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 3.  Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.

Authors:  H Hebart; L Kanz; G Jahn; H Einsele
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

4.  Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

Authors:  G Gerna; M Furione; F Baldanti; A Sarasini
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.